Clinical Trials

Showing trials with last updates posted in 2026.

NCT04404088 | ACTIVE_NOT_RECRUITING | PHASE2
60 participants

Acalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicular Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2020-07-16
Completion:
2028-03-01
Conditions
  • Ann Arbor Stage III Grade 1 Follicular Lymphoma
  • Ann Arbor Stage III Grade 2 Follicular Lymphoma
  • Ann Arbor Stage III Grade 3 Follicular Lymphoma
  • Ann Arbor Stage IV Grade 1 Follicular Lymphoma
  • Ann Arbor Stage IV Grade 2 Follicular Lymphoma
  • Ann Arbor Stage IV Grade 3 Follicular Lymphoma
  • Grade 3a Follicular Lymphoma
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT04292574 | RECRUITING
800 participants

UK SMA Patient Registry

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-20
Start Date:
2008-07-13
Completion:
2040-01-01
Conditions
  • Spinal Muscular Atrophy
  • SMA
Interventions
  • OTHER
No Results Yet
NCT04205968 | RECRUITING | PHASE2
94 participants

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2020-06-01
Completion:
2027-02-01
Conditions
  • Metastatic Small Intestinal Adenocarcinoma
  • Stage III Small Intestinal Adenocarcinoma AJCC v8
  • Stage IIIA Small Intestinal Adenocarcinoma AJCC v8
  • Stage IIIB Small Intestinal Adenocarcinoma AJCC v8
  • Stage IV Small Intestinal Adenocarcinoma AJCC v8
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT04199780 | COMPLETED | NA
106 participants

Effects of tDCS Combined With CBI on Postsurgical Pain

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2021-01-11
Completion:
2026-01-01
Conditions
  • Total Knee Arthroplasty (Postoperative Pain)
  • Total Hip Arthroplasty (Postoperative Pain)
Interventions
  • DEVICE
  • BEHAVIORAL
No Results Yet
NCT04159597 | AVAILABLE

Expanded Access to Upadacitinib

Study Type:
EXPANDED_ACCESS
Last Updated:
2026-08-20
Conditions
  • Crohn Disease
  • Ulcerative Colitis
  • Idiopathic Arthritis (Including sJIA, pJIA, or JPsA)
  • Atopic Dermatitis
  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Axial Spondyloarthritis
  • Non-radiographic Axial
  • Spondyloarthritis
  • Giant Cell Arteritis
  • Systemic Lupus Erythematosus
  • Alopecia Areata
  • Non Segmental Vitiligo
  • Hidradenitis Suppurativa
Interventions
  • DRUG
No Results Yet
NCT04007029 | ACTIVE_NOT_RECRUITING | PHASE1
24 participants

Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2019-10-04
Completion:
2027-08-01
Conditions
  • CD19 Positive
  • CD20 Positive
  • Recurrent Chronic Lymphocytic Leukemia
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Follicular Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma
  • Recurrent Small Lymphocytic Lymphoma
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Follicular Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma
  • Refractory Small Lymphocytic Lymphoma
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page